Bg pattern

ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Almagato Stadapharm 1.5 g oral suspension

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor, pharmacist, or nurse.

  • Keep this leaflet, you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 14 days.

Contents of the Package Leaflet

  1. What is Almagato Stadapharm and what is it used for
  2. What you need to know before taking Almagato Stadapharm
  3. How to take Almagato Stadapharm
  4. Possible side effects
  5. Storage of Almagato Stadapharm
  6. Contents of the pack and further information

1. What is Almagato Stadapharm and what is it used for

Almagato Stadapharm belongs to a group of medicines called antacids, which are compounds that act by neutralizing excess stomach acid.

It is indicated for the relief and symptomatic treatment of heartburn and stomach acid in adults and adolescents from 12 years of age.

You should consult a doctor if it worsens or does not improve after 14 days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Almagato Stadapharm

Do not take Almagato Stadapharm

  • If you are allergic to almagato or any of the other components of this medicine (listed in section 6).
  • If you have Alzheimer's disease.
  • If you have undiagnosed digestive tract bleeding, hemorrhoids, fluid retention (edema), liver complications during pregnancy (toxemia of pregnancy), or diarrhea.

Warnings and Precautions

Consult your doctor, pharmacist, or nurse before taking this medicine:

  • If you have mild or moderate kidney disease, as aluminum and magnesium ions can accumulate in the body over time. In this case, your doctor may recommend a lower dose. This medicine is not recommended in severe renal failure.
  • If you are on a low-phosphorus diet, have diarrhea, malabsorption, or are severely debilitated, as aluminum salts reduce phosphorus absorption, which can cause, especially with prolonged treatment, a decrease in blood phosphate levels (loss of appetite, muscle weakness, general discomfort, etc.) and insufficient bone mineralization (osteomalacia).
  • If you are an elderly patient, as the continued use of antacids containing aluminum can worsen existing bone disease (osteoporosis and osteomalacia) due to reduced phosphorus and calcium levels.

Tell your doctor if you experience any symptoms that indicate digestive tract bleeding, such as vomiting blood or black stools.

Children and Adolescents

Antacids should not be given to children under 12 years of age, as they may mask other existing diseases (e.g., appendicitis). In younger children, there is a risk of increased magnesium levels in the blood or aluminum toxicity, especially if they are dehydrated or have kidney disease.

Other Medicines and Almagato Stadapharm

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicine.

Antacids alter the absorption of many medicines, so, in general, the intake of Almagato Stadapharm 1.5 g should be spaced out (at least 3 hours) from the administration of any other medicine.

It is especially important to inform your doctor if you are taking any of the following medicines:

  • Non-steroidal anti-inflammatory drugs (medicines used to treat pain and inflammation, e.g., flufenamic acid or mefenamic acid, indomethacin)

Anti-ulcer drugs (medicines to treat stomach ulcers or duodenal ulcers and heartburn, among others, e.g., cimetidine, famotidine, ranitidine)

  • Digitalis (medicines to treat heart function disorders, e.g., digoxin, digitoxin)

Antipsychotics (medicines to treat behavioral disorders and psychiatric symptoms, e.g., chlorpromazine)

  • Lansoprazole (medicine to treat stomach ulcers)
  • Corticosteroids (prednisone)
  • Gabapentin (medicine to treat epilepsy)
  • Ketoconazole (medicine to treat fungi)
  • Medicines for the treatment of infections, such as penicillamine, quinolones (ciprofloxacin), tetracyclines (chlotetracycline, demeclocycline, doxycycline)

as this medicine may decrease the absorption of the above-mentioned medicines due to changes in stomach conditions or the formation of poorly soluble complexes.

  • Quinidine (medicine to treat heart rhythm disorders), as Almagato Stadapharm may increase its toxicity by reducing its elimination due to increased urine pH.
  • Salicylates (medicines to relieve pain and reduce fever and inflammation, e.g., acetylsalicylic acid), as this medicine may decrease their concentrations due to increased elimination caused by increased urine pH, especially with high doses of salicylate.

Consult your doctor if you are going to have a stomach composition analysis, as Almagato Stadapharm may alter the test results.

Pregnancy, Breastfeeding, and Fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Pregnancy

Chronic or excessive use of Almagato Stadapharm should be avoided during pregnancy due to the risk of fetal/newborn disorders.

If you need prolonged treatment, consult your doctor, who will indicate the appropriate treatment.

If you are pregnant or think you may be pregnant, consult your doctor or pharmacist before taking any medicine. The use of medicines during pregnancy can be hazardous to the embryo or fetus and should be monitored by your doctor.

Breastfeeding

Chronic or excessive use of medicines containing almagato should be avoided.

Although small amounts of aluminum and magnesium can be eliminated through breast milk in mothers treated with almagato, their concentration is not high enough to cause adverse effects in the infant.

Driving and Using Machines

Almagato Stadapharm does not affect your ability to drive or operate machinery.

Almagato Stadapharm 1.5 g Oral Suspension ContainsSorbitol (E-420)

This medicine contains 1.05 g of sorbitol (E-420) per sachet. Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to certain sugars, or you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medicine.

Almagato Stadapharm 1.5 g Oral Suspension Contains Sulfites

This medicine may cause severe allergic reactions and bronchospasm (sudden feeling of suffocation) because it contains sulfites.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet, so it is considered essentially "sodium-free".

3. How to Take Almagato Stadapharm

Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor, pharmacist, or nurse. If you have any doubts, ask your doctor, pharmacist, or nurse.

Use in Adults and Adolescents:the recommended dose is 1 sachet (1.5 grams of almagato), three times a day, preferably half an hour to one hour after meals. If discomfort recurs, another dose can be taken before bedtime.

Do not exceed 8 grams per day (5 sachets).

Use in Elderly Patients:no dose adjustment is necessary (see "Warnings and Precautions" section).

Use in Patients with Kidney Disease:if you have severe renal failure, this medicine is not recommended (see "Warnings and Precautions" section).

If you have mild or moderate kidney disease, your doctor may recommend lower doses (see "Warnings and Precautions" section).

Almagato Stadapharm should be taken orally.

The sachet should be pressed several times before opening to ensure complete use of its contents. The oral suspension can be taken directly from the sachet or the contents of a sachet can be poured into a half glass of water, stirred, and taken immediately.

If You Take More Almagato Stadapharm Than You Should

At the recommended doses, no intoxication with this medicine is expected. In patients with a low-phosphorus diet and/or prolonged treatment with high doses, a decrease in blood phosphate levels and insufficient bone mineralization may occur.

If you have taken more almagato than you should, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 915 620 420, indicating the medicine and the amount taken.

If You Forget to Take Almagato Stadapharm

Do not take a double dose to make up for forgotten doses. Take the forgotten dose when you can if the time interval is small, or wait for the next dose, provided that there are no discomforts, in which case it can be taken earlier. Take the next doses with the indicated time interval between them.

If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Due to the low intestinal absorption, the side effects of almagato are rare. Occasionally (no data are available to estimate the frequency), diarrhea has been described, which usually disappears after treatment is discontinued.

Reporting of Side Effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines, Website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Almagato Stadapharm

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use this medicine after the expiry date stated on the packaging after CAD. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the pharmacy's SIGRE collection point. If you have any doubts, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the Pack and Further Information

Composition of Almagato Stadapharm 1.5 g Oral Suspension

• The active ingredient is almagato. Each sachet contains 1.5 grams of almagato.

• The other ingredients are: microcrystalline cellulose (E-460), sodium carmellose, sodium saccharin, chlorhexidine diacetate, peppermint flavor (contains sulfites), sorbitol (E-420) 70%, simethicone emulsion (silica, dimethicone, cellulose-based emulsifier, and sodium sorbate), and purified water.

Appearance of the Product and Contents of the Pack

Almagato Stadapharm is presented as a white liquid with a mint flavor.

Each box contains 12, 24, or 50 sachets.

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Laboratory STADA, S.L.

Frederic Mompou, 5

08960 Sant Just Desvern

Spain

Manufacturer

GALENICUM HEALTH, S.L.U.

Sant Gabriel, 50

08950 Esplugues de Llobregat (Barcelona), Spain

or

SAG MANUFACTURING, S.L.U.

Ctra. N-I, km 36

28750 San Agustín de Guadalix (Madrid)

Spain

Date of the Last Revision of this Leaflet: June 2023

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION

Discuss questions about ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (32)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (4)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (34)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION?
ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION?
The active ingredient in ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION is almagate. This information helps identify medicines with the same composition but different brand names.
Who manufactures ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION?
ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION is manufactured by Laboratorio Stada S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ALMAGATO STADAPHARM 1.5 G ORAL SUSPENSION?
Other medicines with the same active substance (almagate) include ALMAGATO STADAPHARM 500 MG CHEWABLE TABLETS, ALMAX 1g/7.5ml ORAL SUSPENSION, ALMAX 500 mg CHEWABLE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media